Future of Spermatogenesis in Men With Sickle Cell Disease Medically Treated

NCT01609192 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Drepanocytic Men Treated by Hydroxyurea for the First Time

Interventions

DRUG: Hydrea® (hydroxyurea )

Sponsor

Assistance Publique - Hôpitaux de Paris